Neurocentria
CA - Walnut CreekBiotechnology
Focus: Neurocentria is a publicly traded small-molecule biotech focused on neurological and psychiatric disorders, headquartered in Walnut Creek, California since 2012.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Neurocentria
AI assessmentNot HiringNo open roles listed right now. Follow Neurocentria to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
L-Threonic Acid Magnesium Salt
Attention Deficit/Hyperactivity DisorderClinical Trials (1)
NCT02558790L-Threonic Acid Magnesium Salt (L-TAMS) in ADHD
Phase 2Help build intelligence for Neurocentria
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.